HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

2021 Could Be Start Of Global Beauty Microplastic Purge

Executive Summary

The European Union’s deliberations in 2021 on a proposed microplastic restriction will determine exactly what and when microplastic ingredients must be removed from cosmetic products on the EU market, likely with global ripple effects.

You may also be interested in...



Group Of European Firms Say EC’s Proposed Ban On Microplastics In Cosmetics Not ‘Far Or Fast Enough’

Firms removing microplastics from cosmetic products maintain European Commission’s deadline for removal across the sector is too generous. Weleda contends nine of 10 personal care products contain microplastics and 7 kg plastics a minute flushed into environment from cosmetics.

Microplastic Must Be Gone From Makeup, Lip, Nail Cosmetics In 12 Years – EU Commission

The Commission’s long-awaited draft regulation extends the phase-out period for microplastic in selected leave-on cosmetics from six to 12 years. That’s a win for industry, but tens of thousands of formulations still must be reformulated in a market where suitable alternative ingredients have been characterized as scarce to nonexistent.

PCPC Leadership On US Legislative Landscape, EU Microplastic Restriction, Other 2021 Concerns

The Personal Care Products Council’s government affairs heads, chief scientist and executive VP of global strategies discuss the trade association’s 2021 priorities and preoccupations.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel